Dr Reddy's to buy JB Chem's drug portfolio for Rs 157 cr

25 Jul 2011 Evaluate

Pharma major Dr. Reddy’s Laboratories Ltd has entered into an agreement with JB Chemicals & Pharmaceuticals to acquire its pharmaceutical prescription portfolio in the Russia and other CIS regions in a $35 million (Rs 157 cr) deal. As per the agreement, the Hyderabad-based company would acquire 20 brands from Mumbai-based JB Chemicals including key brands Metrogyl and Jocet.

Dr. Reddy’s has also entered into a supply agreement with JB Chemicals for the continued manufacturing and supply of these products associated with the acquired brands. Russia is one of Dr. Reddy’s leading markets where it enjoys a strong equity with stakeholders. This acquisition will help expand prescription, hospital and OTC portfolio, complement our existing strong basket of products and add to our growth.crackcrack

Dr. Reddys Lab Share Price

1342.45 16.45 (1.24%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.